RESUMEN
The incidence of Second Primary Tumors in the upper aerodigestive tract varies from 5 to 30 %. Most of them are located either in the same anatomical region or in the lungs, and are related to a poor overall survival. Our objective is to assess the incidence of Second Primary Tumors, factors related to its outcome, frequent associations, and impact on overall survival. 27 patients with Second Primary Tumors were reviewed out of 307 with head and neck cancer, between 2002 and 2011. Patients had a minimum follow-up period of 3 years, or until their death after the last treatment. Sex: 85.2 % were male; male:female ratio of 23:4. The mean age of appearance for the primary tumor was 66.8 years. Only 1 patient had a synchronous Second Primary Tumor, while 26 had metachronous Second Primary Tumors. Second neoplasms were grouped into synchronous and metachronous for statistical analysis. The following parameters were considered: age at diagnosis of the first tumor, gender, smoking and persistence of the habit, primary tumor's location in the larynx, association between two squamous cell carcinomas (index and second primary tumor), and radiotherapy for the primary tumor. The incidence of Second Primary Tumors was 8.79 %. Overall survival of metachronous tumors was 95 months (7.9 years). The primary tumor's location that prevailed when developing a Second Primary Tumor was the larynx. Regarding the histology, the most common association was head and neck squamous cell carcinoma with head and neck squamous cell carcinoma (9 patients). The Second Primary Tumor was the cause of death in 51.9 % of the patients and its most frequent location was the lungs. 19 patients underwent radiotherapy. Second Primary Tumors are common in the head and neck. The authors would like to enforce the importance of an extended follow-up, since second neoplasms worsen considerably the patient's prognosis. Patients who keep on smoking after treatment decrease even more their overall survival.
Asunto(s)
Neoplasias de Cabeza y Cuello/epidemiología , Neoplasias Primarias Secundarias/epidemiología , Anciano , Argentina/epidemiología , Femenino , Neoplasias de Cabeza y Cuello/diagnóstico , Humanos , Incidencia , Masculino , Pronóstico , Tasa de Supervivencia/tendenciasRESUMEN
We report a case of a 75-year-old man submitted to a rectosigmoidectomy and partial cystectomy because of a sigmoid cancer and colovesical fistula. Seven months later and after four cycles of adjuvant chemotherapy, a lesion was detected in the kidney. Histology revealed tubular adenocarcinoma, which meant sigmoid cancer metastasis. Kidney metastases are very rare in colorectal cancer (CRC), but may be generally associated with an unfavorable prognosis. Thus, patients with metastatic CRC and kidney tumors are a diagnostic and therapeutic challenge.
RESUMEN
Purpose: Most head and neck malignant neoplasias are diagnosed in advanced stages. Another threatening element to the patients' survival chances and quality of life is the high risk of developing a second primary tumor (SPT). SPT significantly worsens prognosis, and for that reason patients must be monitored for early diagnosis. The main objective of this study was to analyze the occurrence of SPTs in patients with oral squamous cell carcinoma (OSCC) treated in Erasto Gaertner Hospital (EGH), Curitiba, PR, Brazil, in a period of 16 years. Methods: Design: retrospective study. The sample comprised patients with OSCC who developed SPT between January 1990 and December 2005. Demographic and clinical data were recorded form the patients' medical charts and analyzed with descriptive statistics. Results: During this period, 34,637 patients were admitted at EGH. A total of 1,637 (4.4%) patients were diagnosed with OSCC, and 37 (2.7%) developed a SPT. Patients who developed SPT were 29 (78.4%) male and 8 (21.6%) female, with a median age of 58 years old. The most frequent anatomical SPT site was the mouth, oropharynx and oesophagus, with an overall survival of 27%. Conclusion: Patients treated from OSCC must be carefully monitored because of the increased risk of SPT, especially when there is a continuous history of tobacco and alcohol consumption.
Objetivo: A maioria das neoplasias malignas de cabeça e pescoço é diagnosticada em estágios avançados. O alto risco de desenvolver um segundo tumor primário (STP) diminui a taxa de sobrevida dos pacientes. STP piora significativamente o prognóstico e estudos sobre ele devem ser realizados para se descobrir seus fatores de risco e melhor forma de tratamento. O principal objetivo deste estudo foi analisar a ocorrência de STP em pacientes com carcinoma epidermóide bucal (CEB) tratados no Hospital Erasto Gaertner (HEG), Curitiba, PRP, Brasil, num período de 16 anos. Metodologia: Um estudo retrospectivo foi realizado a fim de revisar os pacientes com CEB que desenvolveram STP entre Janeiro de 1990 e Dezembro de 2005. Os dados demográficos e clínicos foram coletados através dos prontuários médicos dos pacientes e foram analisados por estatística descritiva. Resultados: Neste período, 34.637 pacientes foram admitidos no HEG. Um total de 1637 (4,4%) pacientes recebeu diagnóstico de CEB, dos quais 37 (2,7%) desenvolveram STP. Os pacientes que desenvolveram STP eram 29 (78,4%) homens e 8 (21,6%) mulheres, com média de idade de 58 anos. Os sítios anatômicos mais frequentes para o STP foram a boca, orofaringe e esôfago; a taxa de sobrevivência foi de 27%. Conclusão: Pacientes tratados de CEB devem ser examinados cuidadosamente e monitorados regularmente por causa do alto risco de desenvolver um STP, especialmente aqueles que mantêm os hábitos de tabagismo e etilismo.
Asunto(s)
Humanos , Masculino , Femenino , Carcinoma de Células Escamosas/epidemiología , Neoplasias Primarias Secundarias , Neoplasias de la Boca/epidemiología , Estudios RetrospectivosRESUMEN
Nos primeiros três anos após o tratamento dos pacientes com carcinomas epidermoides de vias aerodigestivas superiores (VADS), observa-se elevada incidência de recidivas. Depois do terceiro ano, o aparecimento de um segundo tumor primário (STP) torna-se importante causa de morbi-mortalidade. OBJETIVO: Avaliar a incidência e o perfil dos STP em pacientes com carcinoma epidermoide de VADS tratados com intenção curativa. MATERIAL E MÉTODO: Estudo retrospectivo em que foram analisadas a incidência, localização e tratamento dos STP e calculada sobrevida. RESULTADOS: Dos 624 casos analisados, 59 (9,4 por cento) tiveram STP durante o seguimento (4 sincrônicos e 55 metacrônicos). A sobrevida livre de STP variou de 2 a 191,3 meses (mediana, 42,5 meses). Em 20 casos (33,9 por cento) o STP foi diagnosticado após o quinto ano de seguimento. O local mais acometido por STP foi a mucosa das VADS (49,1 por cento), seguida pelo pulmão (22,0 por cento) e pelo esôfago (11,9 por cento). A melhor sobrevida pós-STP foi dos casos de STP nas VADS (32,2 por cento em 5 anos, mediana 16,2 meses). CONCLUSÃO: Nos pacientes avaliados a incidência de STP foi de 9,4 por cento. Em 33,9 por cento dos casos o STP foi diagnosticado após o quinto ano de seguimento. A localização mais frequente dos STP foi a mucosa das VADS.
In the first three years after treatment of patients with squamous cell carcinoma of upper aerodigestive tract (UADT), there is a high incidence of recurrences. After the third year, the occurrence of second primary tumor (SPT) is an important cause of morbimortality. AIM: To evaluate the incidence and the characteristics of the SPT in patients with squamous cell carcinoma of UADT, treated with curative intention. METHODS: Retrospective study where the incidence, localization and treatment of SPT had been analyzed and survival rates were calculated. RESULTS: Of the 624 analyzed cases, 59 (9.4 percent) had SPT during follow-up (4 synchronous and 55 metachronous). The SPT free survival rate ranged from 2 to 191.3 months (median of 42.5 months). In 20 cases (33.9 percent) the SPT was diagnosed after the fifth year of follow-up. The most frequent site of STP was the UADT mucosa (49.1 percent), followed by the lungs (22.0 percent) and the esophagus (11.9 percent). The best survival after-SPT occurred in cases of UADT STP (32.2 percent in 5 years, median 16.2 months). CONCLUSION: The STP incidence was 9.4 percent. In 33.9 percent of the cases, the SPT was diagnosed after the fifth year of follow-up. The most frequent localization of STP was the UADT mucosa.